These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36152184)

  • 1. Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Cofactor Recruitment Assay for PPARα and PPARγ.
    Roth D; Benz J; Grether U; Dietz M
    Methods Mol Biol; 2023; 2576():155-169. PubMed ID: 36152184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
    Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
    Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative molecular profiling of the PPARα/γ activator aleglitazar: PPAR selectivity, activity and interaction with cofactors.
    Dietz M; Mohr P; Kuhn B; Maerki HP; Hartman P; Ruf A; Benz J; Grether U; Wright MB
    ChemMedChem; 2012 Jun; 7(6):1101-11. PubMed ID: 22489042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scintillation Proximity Assay (SPA)-Based Radioligand Binding for PPARα, PPARγ, and PPARδ Receptors.
    Grether U; Benz J; Hartung T; Roth D
    Methods Mol Biol; 2023; 2576():145-153. PubMed ID: 36152183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated virtual screening for the identification of novel and selective peroxisome proliferator-activated receptor (PPAR) scaffolds.
    Nevin DK; Peters MB; Carta G; Fayne D; Lloyd DG
    J Med Chem; 2012 Jun; 55(11):4978-89. PubMed ID: 22582973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate.
    Honda A; Kamata S; Akahane M; Machida Y; Uchii K; Shiiyama Y; Habu Y; Miyawaki S; Kaneko C; Oyama T; Ishii I
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and SAR of Natural-Product-Inspired RXR Agonists with Heterodimer Selectivity to PPARδ-RXR.
    Nakashima KI; Yamaguchi E; Noritake C; Mitsugi Y; Goto M; Hirai T; Abe N; Sakai E; Oyama M; Itoh A; Inoue M
    ACS Chem Biol; 2020 Jun; 15(6):1526-1534. PubMed ID: 32374156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QTR-FRET: Efficient background reduction technology in time-resolved förster resonance energy transfer assays.
    Syrjänpää M; Vuorinen E; Kulmala S; Wang Q; Härmä H; Kopra K
    Anal Chim Acta; 2019 Dec; 1092():93-101. PubMed ID: 31708038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A homogeneous in vitro functional assay for estrogen receptors: coactivator recruitment.
    Liu J; Knappenberger KS; Kack H; Andersson G; Nilsson E; Dartsch C; Scott CW
    Mol Endocrinol; 2003 Mar; 17(3):346-55. PubMed ID: 12554768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Basis for Anti-non-alcoholic Fatty Liver Disease and Diabetic Dyslipidemia Drug Saroglitazar as a PPAR α/γ Dual Agonist.
    Honda A; Kamata S; Satta C; Machida Y; Uchii K; Terasawa K; Nemoto A; Oyama T; Ishii I
    Biol Pharm Bull; 2021; 44(9):1210-1219. PubMed ID: 34471049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model.
    Nakano Y; Arima T; Tobita Y; Uchiyama M; Shimizu A; Takahashi H
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present).
    Takada I; Makishima M
    Expert Opin Ther Pat; 2020 Jan; 30(1):1-13. PubMed ID: 31825687
    [No Abstract]   [Full Text] [Related]  

  • 14. Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?
    Gani OA
    Cardiovasc Diabetol; 2008 Mar; 7():6. PubMed ID: 18355413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptors modulate proliferation and angiogenesis in human endometrial carcinoma.
    Nickkho-Amiry M; McVey R; Holland C
    Mol Cancer Res; 2012 Mar; 10(3):441-53. PubMed ID: 22205725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM; Schiffrin EL
    Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cow's milk increases the activities of human nuclear receptors peroxisome proliferator-activated receptors alpha and delta and retinoid X receptor alpha involved in the regulation of energy homeostasis, obesity, and inflammation.
    Suhara W; Koide H; Okuzawa T; Hayashi D; Hashimoto T; Kojo H
    J Dairy Sci; 2009 Sep; 92(9):4180-7. PubMed ID: 19700678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat.
    Juge-Aubry CE; Gorla-Bajszczak A; Pernin A; Lemberger T; Wahli W; Burger AG; Meier CA
    J Biol Chem; 1995 Jul; 270(30):18117-22. PubMed ID: 7629123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural carotenoid astaxanthin, a PPAR-α agonist and PPAR-γ antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes.
    Jia Y; Kim JY; Jun HJ; Kim SJ; Lee JH; Hoang MH; Hwang KY; Um SJ; Chang HI; Lee SJ
    Mol Nutr Food Res; 2012 Jun; 56(6):878-88. PubMed ID: 22707263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver.
    Anderson SP; Dunn C; Laughter A; Yoon L; Swanson C; Stulnig TM; Steffensen KR; Chandraratna RA; Gustafsson JA; Corton JC
    Mol Pharmacol; 2004 Dec; 66(6):1440-52. PubMed ID: 15371561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.